Minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) is an increasingly popular procedure with several potential advantages over traditional open TLIF. OBJECTIVE: The current study aimed to compare fusion rates of different graft materials used in MIS-TLIF, via meta-analysis of the published literature. METHODS: A Medline search was performed and a database was created including patient's type of graft, clinical outcome, fusion rate, fusion assessment modality, and duration of follow-up. Meta-analysis of the fusion rate was performed using StatsDirect software (StatsDirect Ltd, Cheshire, United Kingdom). RESULTS: A total of 1533 patients from 40 series were included. Fusion rates were high, ranging from 91.8% to 99%. The imaging modalities used to assess fusion were computed tomography scans (30%) and X-rays (70%). Comparison of all recombinant human bone morphogenetic protein (rhBMP) series with all non-rhBMP series showed fusion rates of 96.6% and 92.5%, respectively. The lowest fusion rate was seen with isolated use of autologous local bone (91.8%). The highest fusion rate was observed with combination of autologous local bone with bone extender and rhBMP (99.1%). The highest fusion rate without the use of BMP was seen with autologous local bone + bone extender (93.1%). The reported complication rate ranged from 0% to 35.71%. Clinical improvement was observed in all studies. CONCLUSION: Fusion rates are generally high with MIS-TLIF regardless of the graft material used. Given the potential complications of iliac bone harvesting and rhBMP, use of other bone graft options for MIS-TLIF is reasonable. The highest fusion rate without the use of rhBMP was seen with autologous local bone plus bone extender (93.1%).
T ransforaminal lumbar interbody fusion (TLIF) technique was first described by Harms et al in 1982.
1 TLIF has become a popular procedure that has been shown to be associated with favorable clinical and fusion outcomes. [2] [3] [4] ABBREVIATIONS: CT, computed tomography; DBM, demineralized bone matrix; DDD, degenerative disc disease; DH, disc herniation; ICBG, iliac crest bone graft; MIS-TLIF, minimally invasive transforaminal lumbar interbody fusion; ODI, Oswestry Disability Index; PEEK, Polyether ether ketoronate; rhBMP, recombinant human bone morphogenetic protein; VAS, visual analog scale
In the early 2000s, Foley et al 5 introduced a minimally invasive (MIS) modification of the TLIF surgical technique. 5 MIS-TLIF has been shown to have similar clinical results [6] [7] [8] [9] and fusion rates as those of "traditional" open TLIF. 10 It has additional benefits of less blood loss (BL), shorter hospital stay, shorter rehabilitation time, and earlier resumption of previous activities. 3, [11] [12] [13] In addition, MIS procedures have been shown to have lower infection rates compared to open surgery and there is a tendency towards lower overall costs for MIS-TLIF. 14, 15 The success of MIS-TLIF relies on a solid interbody fusion since a posterolateral fusion is difficult to achieve given the limited exposure.
The main difference between various MIS-TLIF techniques in the literature is the type of implants and graft materials utilized for interbody fusion. These implants provide biomechanical stability and keep the endplate-graft complex under load compression to facilitate arthrodesis.
Different types of grafts and fusion enhancers include local cortico-cancellous autologous bone obtained from laminectomy and facetectomy, harvested autologous bone from the iliac crest, allograft bone from a cadaver donor, nonhuman bone substitutes (hydroxyapatite, ceramics) demineralized bone matrix (DBM), and recombinant human bone morphogenetic proteins (rhBMP).
Autologous iliac crest bone graft (ICBG) offers a number of advantages; it has lower costs, is easy to harvest, and thereby avoids the immunologic complications of the allograft. The main disadvantages include the donor site complications (pain, infection, and hematomas), as well as limited quantity of the bone graft, which makes it insufficient when multilevel fusion is intended. 16, 17 Allografts derived from the processed cadaveric bone have advantages of abundant material supply and the avoidance of harvesting complications; yet, they bear the risk of infectious disease transmission (extremely low risk), as well as the risk for immunologic reaction due to the antigenicity. 18 Furthermore, allografts encompass only osteo-conductive activity.
There are more than 50 types of DBM products available for lumbar fusion. 16 The main criticism against use of DBM is wide variability in DBM processing, thereby providing uneven proportions of osteo-inductive substance.
The rhBMPs are members of the transforming growth factorbeta superfamily, discovered in the mid-60s. 19 The US Food and Drug Administration has approved clinical use of 2 types of rhBMPs: rhBMP-7 (OP1 Olympus Corporation, Tokyo 163-0914, Japan) in recalcitrant long bone nonunions and posterolateral lumbar arthrodesis revisions [20] [21] [22] ; and rhBMP-2 for spinal fusion procedures with the LT-CAGE Lumbar Tapered Fusion Device (Medtronic Sofamor Danek, Dublin, Ireland) through the anterior approach in patients with degenerative disc disease (DDD) at 1 level from L4-S1, and later for repair of symptomatic, posterolateral lumbar spine pseudarthrosis. 21, 23, 24 The off-label use of rhBMP-2 in TLIF has been shown to be effective in achieving high fusion rates in the lumbar spine. [25] [26] [27] [28] Nonetheless, the use of rhBMP-2 is limited for 2 main reasons; high costs and reports of its association with complications. 23, 25, 26, 29 To our knowledge there have been no studies comparing the fusion rates between different types of graft materials utilized for MIS-TLIF. In the current study, a meta-analysis of all published literature in the field has been performed (up to the end of 2013) to look for differences in the fusion rates of various types of graft materials.
METHODS

Search Strategy and the Inclusion Criteria
Using the online resources available, first a PubMed search was conducted to look for the keyword "transforaminal lumbar interbody fusion." The articles were narrowed down to those published in English. A total of 424 papers were found. Further search for papers was performed using the references in the retrieved articles. Ultimately, the following inclusion criteria were used to make the final selection of the studies included in the meta-analysis: (1) reporting on minimally invasive case series; (2) studying on adult patient population (18 yr and above); (3) reporting the information on the type of graft material utilized for fusion (used either in the disc space and/or inside the TLIF cage); (4) reporting the fusion rate according to the previously published uniform criteria.
After the primary selection process, 2 different authors screened studies independently. Reviewers were not blinded to the authors, journals, and/or any other data regarding the papers. Studies were included in the meta-analysis as long as both screeners agreed upon them meeting the inclusion criteria. Ultimately, 32 papers were selected for data extraction.
Data Extraction
Data on the following features was extracted for each study: (1) name of the authors; (2) year of publication; (3) type of the study; (4) number of patients; (5) mean age; (6) sex ratio (F:M); (7) initial diagnosis for treated pathologies; (8) type of the MIS approach used; (9) number of fused levels; (10) levels of fusion; (11) fluoroscopy time; (12) operative time; (13) estimated BL; (14) length of hospital stay; (15) pre-and postoperative functional status, including preop and postop Oswestry Disability Index (ODI), and preop and postop back and leg visual analog scale (VAS); (16) minimum and average follow-up duration; (17) type and number of cages used at each level; (18) type of the graft material used into the disc space and into the cage; (19) the fusion assessment method (X-rays vs computed tomography [CT] scans); (20) fusion rates at 6, 12, and 24 mo; (21) fusion and malunion rates at the final followup; (22) and the type and rate of perioperative complications.
In a number of included studies, more than 1 series of patients were presented, having different epidemiological and/or surgical characteristics; those series may or may not have already been separated by the authors into subgroups. The data on those series of patients were put into the database separately. Accordingly, the final number of the series recorded in the current meta-analysis added up to 40 32 were included in the meta-analysis. This was because although partial overlap may have existed between the 2 studies for a small number of patients, the overall study population was large enough in both studies for the overlap to be considered nonsignificant. The 2009 study included only low-grade isthmic spondylolisthesis patients (total number 46), while the 2013 study included patients with low-grade isthmic spondylolisthesis, degenerative spondylolisthesis, foraminal stenosis with central stenosis, degenerative disc disease, and recurrent disc herniation (DH) (total number 44).
Complications and complication rates were recorded and summarized as they were originally reported in their corresponding manuscripts.
Clinical Outcomes
Clinical outcomes were considered as "good" or favorable when the reported postoperative ODI and/or VAS scores significantly improved compared to before surgery.
Radiological Assessment
In our meta-analysis, only those papers that described their fusion assessment method were included. The assessment should have been made using the previously published criteria for radiographic assessment of the fusion, or meet similar, comparable criteria. The criteria included the presence of continuous trabecular bony bridging on CT scans or X-rays, and/or at minimum lack of movement on dynamic plain films. [34] [35] [36] [37] [38] A total of 18 studies that mentioned "postero-lateral fusion" were excluded.
Quality of Studies
Among the 40 included series for the meta-analysis, 25 were retrospective case series and/or cohorts, 14 prospective case series and/or cohorts, as well as 1 prospective randomized study.
All papers were published between 2005 and 2013. There were no older papers on MIS-TLIF given the relative novelty of this surgical technique.
Statistical Analysis
Meta-analysis of the fusion rate (studies were stratified by the type of graft material) was performed using the StatsDirect statistical software (Version 2.7.9, 7/9/2012; StatsDirect Ltd, Cheshire, England). The heterogeneity in the fusion proportion between the individual studies was tested by the chi-square test (ie, Cochrane Q test) and a P-value of ≤.20 was selected to indicate the presence of heterogeneity. In lack of heterogeneity, fixed-effects models were used for meta-analyses. In presence of heterogeneity however (P ≤.20), random-effects models were used. To report the fusion proportions of interest, a binary proportion with exact 95% confidence intervals expressed the result of each study. The pooled fusion proportion (summary) of each particular group was calculated using either a fixed-effects or random-effects (DerSimonian-Laird) models (based on the heterogeneity criteria as defined above). Forest plots were generated to indicate individual studies' fusion proportions, as well as the pooled fusion proportion (summary) for each group.
To perform the meta-analysis of the fusion proportion in each study group (studies were stratified by the type of graft material), publication bias was tested using a funnel plot (a scatter plot of the fusion proportions from individual studies vs a measure of study size or precision). In the previously mentioned plots, more precise studies appear on top and less precise at the bottom and appear symmetrically distributed. If publication bias is present, the plot may appear asymmetrical. Egger's and Begg-Mazumdar test were used for publication bias.
RESULTS
Epidemiological Data
A total of 40 series with 1533 patients were included. Age and sex distribution was found to be homogeneous in almost all series, with the mean age ranging from 44.5 to 66.4 yr. In one series, the mean age was 71.7 yr, since that particular study was specifically reporting the results of MIS-TLIF in older patients. Epidemiological data have been summarized in Table 1 . 3, 4, [6] [7] [8] [9] 11, 12, [20] [21] [22] [23] [24] 27, 28, [30] [31] [32] [33] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] 
Operative and Clinical Data
Indications for surgery were lumbar canal stenosis, spondylolisthesis, disc herniation, degenerative disc disease, and/or other types of lumbar instability ( Table 1 ). The most frequently operated level was L4/L5, followed by L5/S1 (data not shown in tables). The implanted cages were made of Polyether ether ketoronate (PEEK) (Capstone-Medtronic, Dublin, Ireland; Concorde-De Puy, West Chester, Pennsylvania; Leopard-De Puy, West Chester, Pennsylvania; OIC-Stryker, Kalamazoo, Michigan), titanium (Fidji, Geo-Interpore Cross, Biomet, Irving, California), or hydrosorb (Medtronic, Dublin, Ireland; data not shown in tables). In 2 series, only structural allograft was utilized. In 7 series, the TLIF approach was bilateral, and 2 cages were implanted at each level. In other studies, a unilateral approach was used and a single cage was implanted at the index level.
The perioperative data including the operative time, fluoroscopy time, estimated BL, and length of hospital stay have been summarized in Table 2 .
Details of the clinical outcome have been presented in Table 3 . MIS-TLIF showed a high rate of "good" clinical outcome. In all studies significant improvement was observed in clinical outcome scores (and VAS) after the surgery.
The following graft materials and combinations were used. Table 4 .
Lastly, rhBMP was used in 36.5% of all MIS-TLIF cases, local autograft plus rhBMP were used in 21.9%, and local autograft plus bone extenders and rhBMP were used in 14.6%. There was no ICBG used in combination with rhBMP. Further details regarding the combinations of bone graft materials used are listed in Table 5 . 
Meta-Analyses and Hypotheses of the Study
To analyze fusion rates in the current study, first certain subgroups were defined; all studies were assigned to different treatment groups, based on the type of graft material utilized in their patients. As a general rule, groups bearing "A" letter presented studies using rhBMP in their patients, while groups bearing "B" letter presented studies not using rhBMP. Figures 1A  and 1B show the funnel plots for groups A1 and B1, respectively, and plot graphs for groups A1 and B1 are presented in Figures 2A and 2B , respectively. The presence of publication bias was detected in the funnel plots for groups A1 and B1 (P = .005 and P = .04, respectively, by the Begg-Mazumdar rank-correlation test). Definition of different subgroups has been presented in Table 5 .
Afterwards, multiple meta-analyses were performed to calculate pooled fusion rates for different graft materials, and comparison were made between the groups (Table 5) . Similarly, a small number of the group meta-analyses in Table 5 exhibited significant publication bias (data not shown).
Fusion Rates
The following hypotheses were tested.
(1) Patients treated with rhBMP have higher fusion rates compared to those treated without rhBMP. 11 23.7 ± 4.9 9.1 ± 6.1 4.8 ± 2.4 1.6 ± 1.8 6.8 ± 2.2 0.4 ± 0.9 Shunwu et al 2010 22 49. 28 39.2 ± 12 37,4 ± 9.2 5.8 ± 2.9 2.1 ± 2.8 5.7 ± 2.5 2.1 ± 2.1 Dahdaleh et al 2013 28 17.9 ± 18.7 22.7 ± 17.3 5.7 ± 3.1 2.6 ± 3.0 5.7 ± 2.6 2.6 ± 2.4 Wu et al 2012 30 45.9 ± 3.6 17.6 ± 3.0 5.9 ± 1.6 2.5 ± 1.6 5.4 ± 1.8 2.7 ± 1.6 Wu et al 2012 30 46.8 ± 3.8 18.7 ± 3.4 6.3 ± 1.0 2.7 ± 1.8 5.7 ± 1.6 3.0 ± 1.3 Lee et al 2008 44 51. 
TABLE 4
Continued. (2) Autologous local bone alone has a lower fusion rate compared to the combination of autograft and nonautograft bone materials. (3) ICBG results in higher fusion rates compared to noniliac bone grafts when used alone. (4) The difference in fusion rates between rhBMP and nonrhBMP-treated patients stays constant over time (rhBMP stays constantly higher). (5) Studies assessing fusion rates using X-rays report higher fusion rates compared to those using CT scans.
Author and year
Number
In testing hypothesis 1, the meta-analysis of the results found a pooled fusion rate of 96.6% for group A1 (patients treated with rhBMP), and 92.5% for group B1 (patients treated without rhBMP). Plot graphs for groups A1 and B1 are presented in Figures 1B and 2B , respectively.
To test hypothesis 2, a comparison was made between groups B2 and B3, including patients treated with autologous local bone graft without rhBMP (group B2 was treated with isolated autologous local bone, and group B3 was treated with autologous local bone combined with bone extender). A second comparison was also made between groups A2 and A3, including patients treated with autologous local bone graft with rhBMP (group A2 without any other bone extender, and group A3 combined with other bone extenders).
The pooled fusion rate was 91.8% for group B2 and 93.1% for group B3. The fusion rates for groups A2 and A3 and were 95.3% and 99.1%, respectively.
To test hypothesis 3, comparisons were made between groups B4 and B5, including patients treated with iliac crest and all noniliac crest grafts, respectively (both without rhBMP). This was due to the fact that no patients had been treated with combination of iliac rest and rhBMP. This may be due to the fact that surgeons commonly assume a high and similar probability of fusion for rhBMP or ICBG. The fusion rates for groups B4 and B5 were 92.9% and 92.4%, respectively.
To assess hypothesis 4, 4 groups were defined: groups A12m and B-12m, patients with minimum follow-up of 12 mo (with and without rhBMP, respectively); and groups A-24m and B-24m, with minimum follow-up of 24 mo (with and without rhBMP, respectively). At minimum follow-up of 12 mo, fusion rates for patients treated with and without rhBMP were 98.8% and 93.1%, respectively, which in turn increased to 98.9% and 94.4% at 24-mo follow-up. There was no statistically difference in fusion for these groups when compared over time at 12 vs 24 mo (P = .36).
To assess hypothesis 5, groups Imaging 1 and 2 were defined. Group Imaging 1 included studies that assessed the fusion based on X-rays and group Imaging 2 included those that assessed fusion based on CT scans. Fusion rates for groups Imaging 1 and 2 were 94.4% and 90.8%, respectively. NEUROSURGERY VOLUME 81 | NUMBER 6 | DECEMBER 2017 | 965 
Complications
Complication rate varied within a wide range, from 0% (in only 3 series) to as high as 35.71%, while the median rate was 8.82%.
The most frequent complication was found to be pedicle screw malpositioning, followed by dural tear, radiculopathy (related to hardware malposition), cage migration, and wound infection (superficial or deep). Other less common complications included wound dehiscence, hematoma, brachial plexus paralysis due to improper positioning, along with other medical complications (urinary tract infection, pneumonia, pulmonary embolism, ileus).
Pseudoarthrosis (nonunion) was not considered as a complication by most of the authors. Further details regarding the rates and type of complication have been summarized in Table 6 .
DISCUSSION
We have previously shown that MIS-TLIF has similar fusion rates and complication rates compared to open TLIF surgery. 10 In that analysis, we found that >50% of MIS-TLIF procedures were done with the use of rhBMP. This was one of the reasons that stimulated the current review. In the current analysis that included more contemporary studies, we found that rhBMP was used in 32.6% of cases.
Optimal in Maximizing
MIS-TLIF has been proven to be an appropriate surgical technique for fusion in various pathologies of the lumbar spine, such as disc herniation, degenerative disc disease, spondylolisthesis, and/or other causes of instability. It has been shown to be a safe procedure with a low complication rate (despite variability between different studies), and a high potential for avoiding disadvantages and complications of open approaches to the lumbar spine (damage to para-spinal musculature, high BL, postoperative pain, long-term morbidities, and instability due to damage to the ligaments and/or musculature). [2] [3] [4] 6, 7 For example, Villavicencio et al's study 23 on obese patients, who underwent either MIS or open TLIF surgery, showed similar clinical results in both groups, while a significantly lower EBL and complication rate were observed in the MIS group.
However, it is unclear what the optimal bone graft material is that will maximize the rates of interbody fusion for MIS-TLIF. Our study shows that fusion rates for MIS-TLIF are generally high, regardless of the type of graft material utilized; the fusion rates in various studies range from 92% to 99%. Our research showed that when comparing groups with and without rhBMP, the pooled fusion rate was 96.6% for rhBMP group, while it was 92.5% for the non-rhBMP group. The rhBMP group reached a high fusion rate at 1 yr, and did not change significantly thereafter (98.8% at 12-mo follow-up and 98.9% at 24 mo follow-up). In contrast, the fusion rate increased from 93.1% at 12 mo to 94.4% at 24 mo in the non-rhBMP group, but it was not statistically significant.
The question brought up by hypothesis 2 was whether or not isolated autologous local bone graft would be sufficient for MIS-TLIF fusion. The current study showed that addition of rhBMP to autologous local bone graft increases the fusion rate (from 91.8% to 95.3%). In fact, the lowest fusion rate for MIS-TLIF was observed with isolated use of autologous local bone (91.8%). This may in part be due to a relatively lower volume of local bone yielded from MIS-TLIF as compared to open techniques.
Furthermore, comparison between groups B2 and B3 showed that addition of non-rhBMP bone extenders to autologous local bone increases the fusion rate. Nonetheless, autologous local bone combined with bone extender and rhBMP (3 components; group A3) resulted in the highest fusion rate (99.1%). Without rhBMP, however, autologus local bone combined with bone extender or iliac crest had an overall 6% lower fusion rate (group B3; 93.1%).
Testing hypothesis 3 was an effort to identify whether harvesting autologous ICBG would be worthwhile, given its potential for complications, rather than utilization of bone extenders or rhBMP. For this, comparisons were made between series of patients with iliac bone graft (group B4) to those with noniliac bone grafts (group B5); neither groups had additional rhBMP. The group with iliac bone graft showed a fusion rate of 92.9%, while the group with noniliac bone grafts showed 92.4% fusion. The difference was minimal and not statistically significant. Therefore, harvesting ICBG does not seem to provide any advantages in MIS-TLIF.
Testing hypothesis 4 suggested that independent of the observation time, the rhBMP group showed a higher fusion rate, as compared to non-rhBMP group. It also showed that maximum fusion was achieved for patients with rhBMP earlier than patients with non-rhBMP grafts. Nonetheless, conclusions should be drawn with caution in this regard, given the fact that fusion was not evaluated over various time points in all studies, but rather was evaluated at a single time point in most, making testing hypothesis 4 challenging.
Safety of rhBMP has been in question and has been investigated in a number of previous studies. Although our data suggest that rhBMP2 increases fusion rates, there have been reports of it being associated with hyperostosis and inflammation. 20 rhBMP has been associated with de novo cancer, when used at doses above 40 mg, which is of particular concern. 20 However, the potential risk of postoperative cancer formation following the use of BMP in spinal fusion has not been clearly established and this potential side effect must be interpreted on an individual basis for each patient by the surgeon. 52 On the other hand, utilization of less than 5 mg/level of rhBMP has shown good fusion rates and clinical outcome results at long-term follow-up. 32 The fact that rh-BMP is provided at different concentrations from 1 to 12 mg and its application is determined by the individual surgeon makes it difficult to quantify the given dosage per surface area.
Finally, failure to report adverse effects on original rhBMP manufacturer publications undermines confidence of surgeons. Safety of rhBMP must be better and more strongly evidenced regardless of efficacy of the product. 29 At last, comparing groups Imaging 1 and 2 confirmed hypothesis 5. Studies assessing the fusion rate based on X-rays showed a higher fusion rate as compared to those using CT scans, and therefore overestimate the success of fusion surgery. This was independently of the graft that was used. Thus, the methodology used to assess fusion needs to be taken into consideration.
Limitations
There are a few present limitations to this review: (1) the review was conducted retrospectively, and there were no controls; (2) it is still unclear from our review how fusion rates relate to outcome; (3) the side effects of bone grafts on pseudoarthrosis (nonunion) may be considered as a complication. However, since most of the authors did not describe this finding as a complication, this issue remains to be described, separately. (4) The impact of potential confounders on fusion rates, such as fixation constructs, cage type and number, number of levels treated, and diagnosis treated, was not separately evaluated independent of the graft type. Individuallevel covariate information may be needed to perform a regression analysis. Only aggregate information on covariates (per study) is presented. Only meta-analyses of fusion proportions, stratified by the Group definition are presented. Thus, a failure to adjust for these covariates is an obvious limitation of the current study. However, even for group meta-analyses not exhibiting significant publication bias, the Begg-Mazumdar rank-correlation test is known to be susceptible to lower statistical power when the number of component studies is small. Nevertheless, it should be noted that publication bias is less of a concern in meta-analyses of single outcome proportions (eg, pooling of fusion proportions) because no formal effect estimate/resulting P-value is calculated (ie, no direct comparison between groups is made). Thus, the likelihood of nonsignificant findings not being published (ie, the definition of publication bias) is not as relevant in this context. (5) A specific protocol (Flexion-Extension) or fine cut CT scans to assess fusion was not found throughout the studies, which may explain the overestimation of fusion observed on X-rays vs CT.
CONLUSION
Overall, fusion rates for MIS-TLIF are high (above 90%) regardless of graft material used. Utilization of autologous local bone in combination with both bone extender and rhBMP showed the highest fusion rate with a 98.8% at 12-mo follow-up. Isolated use of local bone resulted in the lowest fusion rate of 91.8% at 12-mo follow up. The highest fusion rate without the use of BMP was seen with autologous local bone plus bone extender (93.1%). These rates of fusion and the potential complications associated with rhBMP use or iliac bone harvesting should be taken into consideration by the surgeon before deciding which graft to use during an MIS-TLIF procedure.
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